The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36
- PMID: 19723907
- DOI: 10.3899/jrheum.090193
The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36
Abstract
Objective: We studied patients with systemic lupus erythematosus (SLE) in 1 clinical practice, and patients enrolled in the 1000 Canadian Faces of Lupus database, to determine the minimally important difference (MID) for pain, fatigue, sleep, Health Assessment Questionnaire-Disability Index (HAQ-DI), and Medical Outcomes Study Short Form-36 (SF-36) Physical Component Score (PCS) and SF-36 Mental Component Score (MCS) using a patient-reported overall health status anchor.
Methods: Patients with SLE who had 2 consecutive clinic visits and completed a HAQ-DI and a pain, fatigue, and sleep visual analog scale (VAS) (0-100), and an overall health status question: "How would you describe your overall status since your last visit?": much better, better, the same, worse, or much worse were included. Those who self-rated as better or worse were considered the "minimally changed" subgroups. Patients with 2 consecutive annual visits in the 1000 Canadian Faces of Lupus database who completed the SF-36 and health transition question were eligible.
Results: There were 202 patients in London, Ontario (94% women, mean age 50 yrs, mean disease duration 10 yrs). MID for better and worse on a VAS (0-100) were: pain (-15.8, 8.5), fatigue (-13.9, 9.1), and sleep problems (-8.6, 7.6). The MID for HAQ-DI (scale 0 to 3) was -0.08 (better) and 0.14 (worse). The MID for SF-36 was 2.1 (better) and -2.2 (worse) for the PCS and 2.4 (better) and -1.2 (worse) in the MCS.
Conclusion: The MID in patients with SLE may be different bidirectionally depending on the measured outcome. The mean change observed for those reporting better than worse outcome in pain and fatigue was greater for better versus worst, in contrast to the HAQ, where the mean change was greater for worsening.
Similar articles
-
The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma.J Rheumatol. 2010 Mar;37(3):591-8. doi: 10.3899/jrheum.090375. Epub 2010 Jan 15. J Rheumatol. 2010. PMID: 20080913
-
Minimally important difference for patient-reported outcomes in psoriatic arthritis: Health Assessment Questionnaire and pain, fatigue, and global visual analog scales.J Rheumatol. 2010 May;37(5):1024-8. doi: 10.3899/jrheum.090832. Epub 2010 Mar 15. J Rheumatol. 2010. PMID: 20231193
-
The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials.J Rheumatol. 2009 Feb;36(2):254-9. doi: 10.3899/jrheum.080479. J Rheumatol. 2009. PMID: 19132791
-
The HAQ compared with the MDHAQ: "keep it simple, stupid" (KISS), with feasibility and clinical value as primary criteria for patient questionnaires in usual clinical care.Rheum Dis Clin North Am. 2009 Nov;35(4):787-98, ix. doi: 10.1016/j.rdc.2009.10.011. Rheum Dis Clin North Am. 2009. PMID: 19962623 Review.
-
Sleep disorders and systemic lupus erythematosus.Lupus. 2014 Feb;23(2):115-23. doi: 10.1177/0961203313518623. Lupus. 2014. PMID: 24421291 Review.
Cited by
-
Evaluating the association of preoperative functional status and postoperative functional decline in older patients undergoing major surgery.Am Surg. 2012 Dec;78(12):1336-44. Am Surg. 2012. PMID: 23265122 Free PMC article.
-
Patient-reported outcome measures for use in clinical trials of SLE: a review.Lupus Sci Med. 2018 Aug 21;5(1):e000279. doi: 10.1136/lupus-2018-000279. eCollection 2018. Lupus Sci Med. 2018. PMID: 30167315 Free PMC article.
-
Quality-of-life measurements in multiethnic patients with systemic lupus erythematosus: cross-cultural issues.Curr Rheumatol Rep. 2010 Aug;12(4):237-49. doi: 10.1007/s11926-010-0110-5. Curr Rheumatol Rep. 2010. PMID: 20461481 Review.
-
Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura.Ann Hematol. 2024 Jul;103(7):2523-2531. doi: 10.1007/s00277-024-05771-3. Epub 2024 Apr 27. Ann Hematol. 2024. PMID: 38671298 Free PMC article.
-
Estimating Minimally Important Differences for the Bladder Cancer Index Using Distribution and Anchor Based Approaches.J Urol. 2019 Apr;201(4):709-714. doi: 10.1016/j.juro.2018.10.008. J Urol. 2019. PMID: 30342063 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical